AF-13948

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAF-13948

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionThrombopoietin stimulants

TargetsThrombopoietin

Therapy Area/IndicationsThrombocytopenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A

Related LinksN/A